An interventional study of The Bausch & Lomb Zyoptix Tissue Saving Aspheric algorithm and The Bausch & Lomb Zyoptix Tissue Saving algorithm in Myopia and Astigmatism, sponsored by Bausch & Lomb Incorporated. Completed. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-12-08.
Sponsored by Bausch & Lomb Incorporated · Not applicable, Interventional, and Treatment
The objective of this study was to compare the safety and effectiveness of two versions of the Bausch \& Lomb Zyoptix Tissue Saving Aspheric Algorithm versus the current Zyoptix Tissue Saving Algorithm when used for myopia and myopic astigmatism LASIK treatment.
984 studies on the registry are indexed under Myopia; 210 are open to participants now.
This study's enrollment of 127 is above the median of 80 across 783 interventional studies indexed under Myopia.
Browse Myopia studies →Bausch & Lomb Incorporated is the lead sponsor of 219 studies on the registry; 7 are open to participants now.
Of its 49 completed or terminated interventional studies of FDA-regulated products, 41 (84%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The Bausch \& Lomb Zyoptix Tissue Saving Aspheric algorithm is used for treatment with LASIK for the correction of myopia and myopic astigmatism.
Device: The Bausch & Lomb Zyoptix Tissue Saving Aspheric algorithm
The Bausch \& Lomb Zyoptix Tissue Saving algorithm is used for treatment with LASIK for the correction of myopia and myopic astigmatism.
Device: The Bausch & Lomb Zyoptix Tissue Saving algorithm
Used with LASIK treatment for the correction of myopia and myopic astigmatism.
Used with LASIK treatment for the correction of myopia and myopic astigmatism.
Uncorrected visual acuity
Time frame: At 90 days post surgery
Preservation of best spectacle corrected high contrast logMAR distance visual acuity compared to baseline.
Time frame: At 90 days post surgery
Deviation from target correction
Time frame: At 90 days post surgery
Improvement in uncorrected distance high contrast logMAR visual acuity compared to baseline
Time frame: At 90 days post surgery
No study locations are listed for this record.
This study is completed, as verified in Dec 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bausch & Lomb Incorporated